Research Analysts’ Recent Ratings Updates for Fresenius Medical Care AG & Co. KGaA (FMS)

A number of research firms have changed their ratings and price targets for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS):

• 5/9/2026 – Fresenius Medical Care AG & Co. KGaA was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/8/2026 – Fresenius Medical Care AG & Co. KGaA was upgraded by Jefferies Financial Group Inc. from “strong sell” to “moderate sell”.
• 5/7/2026 – Fresenius Medical Care AG & Co. KGaA was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
• 5/6/2026 – Fresenius Medical Care AG & Co. KGaA had its “underweight” rating reaffirmed by Morgan Stanley.
• 4/26/2026 – Fresenius Medical Care AG & Co. KGaA was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 4/24/2026 – Fresenius Medical Care AG & Co. KGaA had its “neutral” rating reaffirmed by Citigroup Inc..
• 4/18/2026 – Fresenius Medical Care AG & Co. KGaA was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 4/4/2026 – Fresenius Medical Care AG & Co. KGaA was downgraded by Wall Street Zen from “strong-buy” to “buy”.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently declared an annual dividend, which will be paid on Monday, June 8th. Stockholders of record on Friday, May 22nd will be paid a $0.8716 dividend. The ex-dividend date of this dividend is Friday, May 22nd. This is a positive change from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. This represents a dividend yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s payout ratio is currently 30.00%.

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.